Does any CEO deserve $500 million a year? How did Moderna hit it big? And who wants to run Biogen? STAT's Bob Herman joins us to explain why health care CEOs get paid so much — and why company-reported numbers don't tell the full story. Wall Street Journal reporter Peter Loftus calls in to talk about his book chronicling how Moderna went from secretive startup to household name. And we discuss the latest news in the life sciences, including Amazon's latest multibillion-dollar foray into primary care and Biogen's search for a new CEO.
view more